Sengenics is a functional proteomics company leveraging patented KREX tech for autoantibody biomarker discovery, drug response prediction & patient stratification via full-length, correctly folded proteins.
Headquarters:
United States of America
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2008 (17 years)
Address:
WILMINGTON, DELAWARE 19801, US
At a glanceThe company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
LOW
spending power
